The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4aS,8aR)-2-(1-(2-Aminopyrimidin-4-yl)piperidin-4-yl)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one ID: ALA4522249
PubChem CID: 155543093
Max Phase: Preclinical
Molecular Formula: C25H30N6O3
Molecular Weight: 462.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C2=NN(C3CCN(c4ccnc(N)n4)CC3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC
Standard InChI: InChI=1S/C25H30N6O3/c1-33-20-8-7-16(15-21(20)34-2)23-18-5-3-4-6-19(18)24(32)31(29-23)17-10-13-30(14-11-17)22-9-12-27-25(26)28-22/h3-4,7-9,12,15,17-19H,5-6,10-11,13-14H2,1-2H3,(H2,26,27,28)/t18-,19+/m0/s1
Standard InChI Key: UAHRMESTJPCBFW-RBUKOAKNSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
13.5029 -6.0340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5017 -6.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2139 -7.2707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2121 -5.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9249 -6.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9256 -6.8535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6383 -7.2647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3507 -6.8498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3459 -6.0235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6327 -5.6201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6400 -8.0860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6278 -4.8039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3391 -4.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3351 -3.5675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6206 -3.1618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9086 -3.5786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9161 -4.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6152 -2.3405 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3243 -1.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0641 -7.2597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0630 -8.0776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7682 -8.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4809 -8.0755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4796 -7.2532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7658 -6.8388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1927 -8.4840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9199 -5.2127 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
14.9199 -7.6684 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
14.1978 -3.1753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1917 -2.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1910 -9.3033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6127 -9.2994 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9024 -9.7080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8928 -8.0721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6079 -8.4729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9043 -10.5252 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 1 0
5 4 1 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
15 18 1 0
18 19 1 0
8 20 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
23 26 1 0
5 27 1 1
6 28 1 1
16 29 1 0
29 30 1 0
26 31 2 0
31 33 1 0
32 35 1 0
34 26 1 0
32 33 2 0
34 35 2 0
33 36 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 462.55Molecular Weight (Monoisotopic): 462.2379AlogP: 2.87#Rotatable Bonds: 5Polar Surface Area: 106.17Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.31CX LogP: 2.50CX LogD: 2.25Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.68Np Likeness Score: -0.68
References 1. Salado IG, Singh AK, Moreno-Cinos C, Sakaine G, Siderius M, Van der Veken P, Matheeussen A, van der Meer T, Sadek P, Gul S, Maes L, Sterk GJ, Leurs R, Brown D, Augustyns K.. (2020) Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds., 63 (7): [PMID:32196340 ] [10.1021/acs.jmedchem.9b00985 ]